MNKD-201

· MannKind Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MNKD-201, covering 2026-04-16 to 2026-04-16. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate Safety, Tolerability and Pharmacokinetics of MNKD-201 in Patients With Idiopathic Pulmonary Fibrosis [Phase 1]

See pricing